Abstract
Treatment using proton beam has advantages over X-rays due to its physical characteristics, which allow for dose escalation of the tumor with less scatter radiation dose to the surrounding tissues. There have been multiple published reports showing excellent clinical outcomes after treatment with proton therapy for prostate cancer. However, there continues to be significant controversy regarding the clinical advantage of proton therapy over using X-rays with intensity-modulated radiation therapy (IMRT) as there have been no randomized trials comparing the two treatments reported. This chapter will summarize the physics of the proton therapy and the recent technical advances in the delivery of the proton beam, review the clinical results, and describe the treatment protocol used at our institution for the use of proton therapy in the treatment of prostate cancer patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wilson RR. Radiological use of fast protons. Radiology. 1946;45(7):487–91.
Particle Therapy Co-Operative Group (PTCOG) website.
Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53(5):1097–105.
Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(1):67–74.
Zietman AL, Bae K, Slater JD, et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American college of radiology 95–09″. JCO. 2010;28(7):1106–11.
Zhu XR, Sahoo N, Zhang X, et al. Intensity modulated proton therapy treatment planning using single-field optimization: the impact of monitor unit constraints on plan quality. Med Phys. 2010;37(3):1210–9.
Pedroni E, Bacher R, Blattmann H, et al. The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. Med Phys. 1995;22(1):37–53.
Haberer T, Becher W, Schardt D, et al. Magnetic scanning system for heavy ion therapy. Nucl Instrum Methods Phys Res A. 1993;330:296–305.
Al-Mamgani A, van Putten WL, Heemsbergen WD, et al. Update of Dutch multicenter dose-escalation trial for radiotherapy for localized prostate cancer. Int J Radiat Biol Phys. 2008;72(4):980–8.
Talcott JA, Rossi C, Shipley WU, et al. Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. JAMA. 2010;303(11):1046–53.
Slater JD, Rossi CJ, Yonemoto LT, et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys. 2004;59(2):348–52.
Bryant C, Smith TL, Henderson RH, et al. Five-year biochemical results, toxicity, and patient-reported quality of life after delivery of dose-escalated image guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2016;95(1):422–34.
Pugh TJ, Munsell MF, Choi S, et al. Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2013;87(5):946–53.
Hoppe BS, Michalski JM, Mendenhall NP, et al. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer. 2014;120(7):1076–82.
Fang P, Mick R, Deville C, et al. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Cancer. 2015;121(7):1118–27.
Yu JB, Soulos PR, Herrin J, et al. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst. 2013;105(1):25–32.
Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56(1):83–8.
Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65(1):1–7.
Fontenot JD, Lee AK, Newhauser WD. Int J Radiat Oncol Biol Phys. 2009;74(2):616–22.
Cheung J, Kudchadker RJ, Zhu XR, et al. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer. Phys Med Biol. 2010;55(23):7135–47.
Sejpal SV, Amos RA, Bluett JB, et al. Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plans. Int J Radiat Oncol Biol Phys. 2009;75(1):40–8.
Meyer J, Bluett JB, Amos RA, et al. Spot scanning proton beam therapy for prostate cancer: treatment planning technique and analysis of consequences of rotational and translational alignment error. Int J Radiat Oncol Biol Phys. 2010;78(2):428–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Choi, S. (2017). Proton Therapy for the Treatment of Prostate Cancer. In: Ozyigit, G., Selek, U. (eds) Principles and Practice of Urooncology. Springer, Cham. https://doi.org/10.1007/978-3-319-56114-1_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-56114-1_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56113-4
Online ISBN: 978-3-319-56114-1
eBook Packages: MedicineMedicine (R0)